Results 331 to 340 of about 396,884 (345)

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

Nature, 1995
Songyang Zhou, K. Carraway, M. Eck, S. Harrison, R. Feldman, M. Mohammadi, J. Schlessinger, S. Hubbard, Darrin P. Smith, C. Eng, M. J. Lorenzo, B. Ponder, B. Mayer, L. Cantley   +13 more
semanticscholar   +1 more source

Protein Tyrosine Kinase Receptor Signaling Overview

2003
openaire   +1 more source

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly  

Breast cancer statistics, 2017, racial disparity in mortality by state

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis, Ann Goding Sauer Msph, Lisa A Newman   +2 more
exaly  

[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase.

Journal of Medicinal Chemistry, 1995
P. Traxler, U. Trinks, E. Buchdunger, H. Mett, T. Meyer, M. Müller, U. Regenass, J. Rösel, N. Lydon   +8 more
semanticscholar   +1 more source

Gastroenteropancreatic Neuroendocrine Tumors

Ca-A Cancer Journal for Clinicians, 2018
Mauro Cives
exaly  

A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases.

EMBO Journal, 1996
V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, K. Alitalo   +8 more
semanticscholar   +1 more source

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly